We are live on ! Find out more
VP

venBio Partners Portfolio holdings

AUM $519M
1-Year Est. Return 339.42%
This Fund
S&P 500
This Quarter Est. Return
+16.8%
1 Year Est. Return
+339.42%
3 Year Est. Return
+563.8%
5 Year Est. Return
+1,003.88%
10 Year Est. Return
–
AUM
$162M
AUM Growth
+$61.5M
Cap. Flow
+$49.4M
Cap. Flow %
30.43%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
YARW
Yarrow Bioscience
YARW
+$49.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 51.22%
2 Miscellaneous 48.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YARW
1
Yarrow Bioscience
YARW
$98.8M
$54.9M 33.85%
+406
New +$49.4M
VRNA
2
DELISTED
Verona Pharma
VRNA
$17.5M 10.79%
875,000
– –
NBRV
3
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$10.7M 6.58%
8,492
– –

Similar funds

CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
CFG
Compton Financial Group Towson, Maryland $519M AUM 14.76% 1-Year Est. Return
MWM
Mindset Wealth Management Indianapolis, Indiana $519M AUM 46.03% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $520M AUM 21.73% 1-Year Est. Return
WS
Wendel SE Paris $519M AUM 48.2% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
MWC
MBM Wealth Consultants Chesterfield, Missouri $519M AUM 16.88% 1-Year Est. Return
PDIP
Palo Duro Investment Partners Chicago, Illinois $518M AUM 22.62% 1-Year Est. Return

venBio Partners's Q1 2018 Portfolio in Review

As of Q1 2018, venBio Partners held 4 positions worth $162M, up 61% from $101M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

venBio Partners deployed $49.4M of net new capital in Q1 2018, opening 1 new position. Its largest new stake was Yarrow Bioscience: 406 shares worth $54.9M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 23% a quarter earlier, followed by Miscellaneous.

  • venBio Partners's largest Q1 2018 buy was Yarrow Bioscience: 406 shares worth $54.9M.
  • venBio Partners's ten largest holdings make up 100% of its $162M portfolio in Q1 2018.
  • venBio Partners opened 1 new position and closed 0 in Q1 2018.
  • venBio Partners's portfolio value rose 61% quarter-over-quarter to $162M.

Based on venBio Partners's 13F filing for Q1 2018, filed 25 Apr 2018.